数位健康证据市场规模、份额和成长分析：按数位健康平台、最终用户和地区划分 - 2026-2033 年产业预测

2024年全球数位健康证据市场价值为72亿美元，预计将从2025年的88.3亿美元成长到2033年的453.9亿美元。预测期（2026-2033年）的复合年增长率预计为22.7%。

全球数位健康证据市场的主要驱动力是相关人员对可靠的真实世界数据的需求，这些数据能够证明临床效益和价值，并影响关键的采纳和报销决策。该领域专注于数据收集、分析和检验，以满足监管标准，使开发商、支付方和医疗服务提供者能够评估数位健康创新相关的安全性、有效性和成本效益。随着支付方要求可验证的价值，临床医生寻求可靠的指标来进行整合，该市场已发展为国家註册系统和可操作性试验。此外，监管机构和支付方在真实世界证据标准方面的合作有助于实现扩充性和可重复的结果。人工智慧的进步透过自动纠错和异常检测增强了数据检验，透过整合管治流程促进了可靠证据的生成，同时降低了成本并提高了研究准备度。

全球数位健康证据市场的驱动因素

全球数位健康证据市场正受到远端患者监护平台兴起的显着推动，这些平台能够持续收集传统医疗环境之外的健康数据。这种转变增加了对专注于证据聚合、检验和决策支援工具的需求。这些创新提高了获取真实世界患者数据的途径，并能够追踪患者的长期预后，从而推动了医疗机构和技术供应商对数位证据解决方案的投资。此外，远端监测与分析和临床流程的无缝集成，增强了其价值提案，并推动了市场成长，因为相关人员正在寻求检验的证据，以用于确定治疗路径、报销策略和营运效率。

全球数位健康证据市场的限制因素

由于对资料隐私和安全的日益关注，全球数位健康证据市场面临许多限制因素。各机构的谨慎程度不断提高，导致合规要求更加严格，采购流程也更加漫长。相关人员在评估必要的法律和技术保障措施时，往往会推迟投资，因为他们担心病患隐私外洩的风险和潜在的资料外洩。此外，遵守各种法规结构和建立健全的管治也使供应商的发展变得更加复杂。这种复杂性阻碍了快速部署，限制了跨境数据共用，并最终减缓了数位健康证据解决方案在医疗保健系统中的扩充性和应用。

全球数位健康证据市场趋势

全球数位健康证据市场日益关注互通性和生态系统整合，推动平台向能够无缝交换临床和营运资讯的平台转型。这一趋势凸显了标准化介面和API驱动的工作流程的重要性，它们能够简化实施流程，最大限度地减少工作流程中断，并最终促进从日常实践中高效收集证据。随着医疗生态系统内伙伴关係的不断深化，协作式互通性测试变得至关重要，有助于提升相关人员之间的便利性和信任度。这种整合方法不仅为知情临床路径和报销讨论奠定了坚实的基础，还有助于深入了解长期照护路径，从而塑造数位健康的未来。

目录

介绍

• 调查目的
• 市场定义和范围

调查方法

• 研究过程
• 二级资料和一级资料的方法
• 市场规模估算方法

执行摘要

• 全球市场展望
• 市场主要亮点
• 细分市场概览
• 竞争环境概述

市场动态及展望

• 总体经济指标
• 促进者和机会
• 抑制因素和挑战
• 供给面趋势
• 需求面趋势
• 波特的分析和影响

市场考察

• 关键成功因素
• 影响市场的因素
• 主要投资机会
• 生态系测绘
• 2025年市场吸引力指数
• PESTEL 分析
• 监理情势

全球数位健康证据市场规模：按数位健康平台和复合年增长率划分（2026-2033 年）

• 远端医疗平台
• 穿戴式装置

全球数位健康证据市场规模：按最终用户和复合年增长率划分（2026-2033 年）

• 医院和诊所
• 运动员
• 其他的

全球数位健康证据市场规模及复合年增长率（2026-2033）

• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场公司采取的策略
• 近期市场趋势
• 企业市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 按细分市场进行企业市占率分析
  • 2023-2025年营收年比比较

主要企业简介

• Epic Systems Corporation
• Cerner Corporation
• Allscripts Healthcare Solutions
• Medidata Solutions
• Health Catalyst
• Flatiron Health
• Omada Health
• WellDoc
• Pear Therapeutics
• Carrot Health
• HealthLoop
• Verily Life Sciences
• LifeQ
• Aetion
• Biofourmis
• Evidation Health
• Caresyntax
• MDLive
• Doximity
• Zocdoc

结论与建议

Global Digital Health Evidence Market size was valued at USD 7.2 Billion in 2024 and is poised to grow from USD 8.83 Billion in 2025 to USD 45.39 Billion by 2033, growing at a CAGR of 22.7% during the forecast period (2026-2033).

The global digital health evidence market is predominantly driven by healthcare stakeholders' demand for strong real-world data that illustrates clinical benefits and value, influencing crucial adoption and reimbursement decisions. This sector focuses on data collection, analytics, and regulatory-quality validation, enabling developers, payers, and providers to assess safety, effectiveness, and cost outcomes associated with digital health innovations. With payers requiring demonstrable value and clinicians seeking reliable indicators for integration, the market has evolved into national registries and pragmatic trials. Additionally, alignment between regulators and payers on real-world evidence standards promotes scalability and reproducible outcomes. Advancements in AI enhance data validation through automated error correction and anomaly detection, fostering more reliable evidence generation while lowering costs and enhancing study readiness through integrated governance processes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Digital Health Evidence market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Digital Health Evidence Market Segments Analysis

Global digital health evidence market is segmented by digital health platforms, end-user and region. Based on digital health platforms, the market is segmented into Telehealth Platforms and Wearable Devices. Based on end-user, the market is segmented into Hospitals and Clinics, Sportsman and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Digital Health Evidence Market

The Global Digital Health Evidence market is significantly driven by the emergence of remote patient monitoring platforms, which allow for the ongoing collection of health data beyond conventional healthcare environments. This shift creates a heightened demand for tools focused on evidence aggregation, validation, and decision support. By improving access to real-world patient data and enabling the tracking of outcomes over time, these innovations encourage both healthcare organizations and technology vendors to invest in digital evidence solutions. Furthermore, the seamless integration of remote monitoring with analytics and clinical processes enhances their value proposition, propelling market growth as stakeholders pursue validated evidence to inform care pathways, reimbursement strategies, and operational effectiveness.

Restraints in the Global Digital Health Evidence Market

The global digital health evidence market faces significant constraints due to rising concerns surrounding data privacy and security. Organizations are becoming increasingly cautious, leading to stricter compliance requirements and extended procurement processes. When stakeholders are apprehensive about patient confidentiality risks and the potential for data breaches, they often postpone investments while assessing necessary legal and technical safeguards. Additionally, the necessity to adhere to various regulatory frameworks and establish strong governance complicates development for vendors. This complexity hinders quick deployment and limits cross-border data sharing, ultimately decelerating the scalability and adoption of digital health evidence solutions within health systems.

Market Trends of the Global Digital Health Evidence Market

The Global Digital Health Evidence market is increasingly focusing on interoperability and ecosystem integration, driving a significant shift towards platforms that facilitate the seamless exchange of clinical and operational information. This trend emphasizes the importance of standardized interfaces and API-driven workflows, which streamline implementations and minimize workflow disruptions, ultimately promoting efficient evidence aggregation from routine care. As partnerships within the healthcare ecosystem deepen, collaborative interoperability testing becomes vital, enhancing usability and fostering trust among stakeholders. This integrated approach not only strengthens the foundation for informed clinical pathways and reimbursement discussions but also nurtures insights into longitudinal care pathways, shaping the future of digital health.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Digital Health Evidence Market Size by Digital Health Platforms & CAGR (2026-2033)

• Market Overview
• Telehealth Platforms
• Wearable Devices

Global Digital Health Evidence Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Hospitals and Clinics
• Sportsman
• Others

Global Digital Health Evidence Market Size & CAGR (2026-2033)

• North America (Digital Health Platforms, End-User)
  • US
  • Canada
• Europe (Digital Health Platforms, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Digital Health Platforms, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Digital Health Platforms, End-User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Digital Health Platforms, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Epic Systems Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cerner Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allscripts Healthcare Solutions
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medidata Solutions
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Health Catalyst
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Flatiron Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Omada Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WellDoc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pear Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Carrot Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HealthLoop
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Verily Life Sciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LifeQ
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aetion
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biofourmis
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Evidation Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Caresyntax
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MDLive
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Doximity
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zocdoc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations